Global and United States Recombinant Coagulation Factors Market Report & Forecast 2023-2028

Report ID: 1719868 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Recombinant Coagulation Factors Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Recombinant Coagulation Factors Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Recombinant Coagulation Factors Market Size for the Year 2017-2028
        1.2.2 Global Recombinant Coagulation Factors Market Size for the Year 2017-2028
    1.3 Recombinant Coagulation Factors Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Recombinant Coagulation Factors in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Recombinant Coagulation Factors Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Recombinant Coagulation Factors Market Dynamics
        1.4.1 Recombinant Coagulation Factors Industry Trends
        1.4.2 Recombinant Coagulation Factors Market Drivers
        1.4.3 Recombinant Coagulation Factors Market Challenges
        1.4.4 Recombinant Coagulation Factors Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Recombinant Coagulation Factors by Type
    2.1 Recombinant Coagulation Factors Market Segment by Type
        2.1.1 Recombinant Factor VIII
        2.1.2 Recombinant Factor IX
        2.1.3 Von Willebrand Factor
    2.2 Global Recombinant Coagulation Factors Market Size by Type (2017, 2022 & 2028)
    2.3 Global Recombinant Coagulation Factors Market Size by Type (2017-2028)
    2.4 United States Recombinant Coagulation Factors Market Size by Type (2017, 2022 & 2028)
    2.5 United States Recombinant Coagulation Factors Market Size by Type (2017-2028)
3 Recombinant Coagulation Factors by Application
    3.1 Recombinant Coagulation Factors Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Research Organizations
    3.2 Global Recombinant Coagulation Factors Market Size by Application (2017, 2022 & 2028)
    3.3 Global Recombinant Coagulation Factors Market Size by Application (2017-2028)
    3.4 United States Recombinant Coagulation Factors Market Size by Application (2017, 2022 & 2028)
    3.5 United States Recombinant Coagulation Factors Market Size by Application (2017-2028)
4 Global Recombinant Coagulation Factors Competitor Landscape by Company
    4.1 Global Recombinant Coagulation Factors Market Size by Company
        4.1.1 Top Global Recombinant Coagulation Factors Companies Ranked by Revenue (2021)
        4.1.2 Global Recombinant Coagulation Factors Revenue by Player (2017-2022)
    4.2 Global Recombinant Coagulation Factors Concentration Ratio (CR)
        4.2.1 Recombinant Coagulation Factors Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Recombinant Coagulation Factors in 2021
        4.2.3 Global Recombinant Coagulation Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Recombinant Coagulation Factors Headquarters, Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Recombinant Coagulation Factors Headquarters and Area Served
        4.3.2 Global Recombinant Coagulation Factors Companies Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Recombinant Coagulation Factors Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Recombinant Coagulation Factors Market Size by Company
        4.5.1 Top Recombinant Coagulation Factors Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Recombinant Coagulation Factors Revenue by Players (2020, 2021 & 2022)
5 Global Recombinant Coagulation Factors Market Size by Region
    5.1 Global Recombinant Coagulation Factors Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Recombinant Coagulation Factors Market Size by Region (2017-2028)
        5.2.1 Global Recombinant Coagulation Factors Market Size by Region: 2017-2022
        5.2.2 Global Recombinant Coagulation Factors Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Recombinant Coagulation Factors Market Size YoY Growth 2017-2028
        6.1.2 North America Recombinant Coagulation Factors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Recombinant Coagulation Factors Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Recombinant Coagulation Factors Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Recombinant Coagulation Factors Market Size YoY Growth 2017-2028
        6.3.2 Europe Recombinant Coagulation Factors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Recombinant Coagulation Factors Market Size YoY Growth 2017-2028
        6.4.2 Latin America Recombinant Coagulation Factors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Recombinant Coagulation Factors Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Recombinant Coagulation Factors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Baxter International Inc.
        7.1.1 Baxter International Inc. Company Details
        7.1.2 Baxter International Inc. Business Overview
        7.1.3 Baxter International Inc. Recombinant Coagulation Factors Introduction
        7.1.4 Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.1.5 Baxter International Inc. Recent Development
    7.2 Bayer AG
        7.2.1 Bayer AG Company Details
        7.2.2 Bayer AG Business Overview
        7.2.3 Bayer AG Recombinant Coagulation Factors Introduction
        7.2.4 Bayer AG Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.2.5 Bayer AG Recent Development
    7.3 Biogen Idec
        7.3.1 Biogen Idec Company Details
        7.3.2 Biogen Idec Business Overview
        7.3.3 Biogen Idec Recombinant Coagulation Factors Introduction
        7.3.4 Biogen Idec Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.3.5 Biogen Idec Recent Development
    7.4 CSL Ltd.
        7.4.1 CSL Ltd. Company Details
        7.4.2 CSL Ltd. Business Overview
        7.4.3 CSL Ltd. Recombinant Coagulation Factors Introduction
        7.4.4 CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.4.5 CSL Ltd. Recent Development
    7.5 Grifols International SA
        7.5.1 Grifols International SA Company Details
        7.5.2 Grifols International SA Business Overview
        7.5.3 Grifols International SA Recombinant Coagulation Factors Introduction
        7.5.4 Grifols International SA Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.5.5 Grifols International SA Recent Development
    7.6 Kedrion S.P.A.
        7.6.1 Kedrion S.P.A. Company Details
        7.6.2 Kedrion S.P.A. Business Overview
        7.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Introduction
        7.6.4 Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.6.5 Kedrion S.P.A. Recent Development
    7.7 Novo Nordisk A/S
        7.7.1 Novo Nordisk A/S Company Details
        7.7.2 Novo Nordisk A/S Business Overview
        7.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Introduction
        7.7.4 Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.7.5 Novo Nordisk A/S Recent Development
    7.8 Octapharma AG
        7.8.1 Octapharma AG Company Details
        7.8.2 Octapharma AG Business Overview
        7.8.3 Octapharma AG Recombinant Coagulation Factors Introduction
        7.8.4 Octapharma AG Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.8.5 Octapharma AG Recent Development
    7.9 Pfizer Inc.
        7.9.1 Pfizer Inc. Company Details
        7.9.2 Pfizer Inc. Business Overview
        7.9.3 Pfizer Inc. Recombinant Coagulation Factors Introduction
        7.9.4 Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2017-2022)
        7.9.5 Pfizer Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Recombinant Coagulation Factors Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Recombinant Coagulation Factors Market Trends
    Table 3. Recombinant Coagulation Factors Market Drivers
    Table 4. Recombinant Coagulation Factors Market Challenges
    Table 5. Recombinant Coagulation Factors Market Restraints
    Table 6. Global Recombinant Coagulation Factors Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Recombinant Coagulation Factors Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Recombinant Coagulation Factors Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Recombinant Coagulation Factors Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Recombinant Coagulation Factors Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Recombinant Coagulation Factors Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Recombinant Coagulation Factors Revenue Share by Player, 2017-2022
    Table 13. Global Recombinant Coagulation Factors Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Recombinant Coagulation Factors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factors as of 2021)
    Table 15. Top Players of Recombinant Coagulation Factors in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Recombinant Coagulation Factors Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Recombinant Coagulation Factors Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Recombinant Coagulation Factors Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Recombinant Coagulation Factors Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Recombinant Coagulation Factors Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Recombinant Coagulation Factors Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Recombinant Coagulation Factors Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Recombinant Coagulation Factors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Recombinant Coagulation Factors Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Recombinant Coagulation Factors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Recombinant Coagulation Factors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Recombinant Coagulation Factors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Baxter International Inc. Company Details
    Table 31. Baxter International Inc. Business Overview
    Table 32. Baxter International Inc. Recombinant Coagulation Factors Product
    Table 33. Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 34. Baxter International Inc. Recent Development
    Table 35. Bayer AG Company Details
    Table 36. Bayer AG Business Overview
    Table 37. Bayer AG Recombinant Coagulation Factors Product
    Table 38. Bayer AG Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 39. Bayer AG Recent Development
    Table 40. Biogen Idec Company Details
    Table 41. Biogen Idec Business Overview
    Table 42. Biogen Idec Recombinant Coagulation Factors Product
    Table 43. Biogen Idec Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 44. Biogen Idec Recent Development
    Table 45. CSL Ltd. Company Details
    Table 46. CSL Ltd. Business Overview
    Table 47. CSL Ltd. Recombinant Coagulation Factors Product
    Table 48. CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 49. CSL Ltd. Recent Development
    Table 50. Grifols International SA Company Details
    Table 51. Grifols International SA Business Overview
    Table 52. Grifols International SA Recombinant Coagulation Factors Product
    Table 53. Grifols International SA Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 54. Grifols International SA Recent Development
    Table 55. Kedrion S.P.A. Company Details
    Table 56. Kedrion S.P.A. Business Overview
    Table 57. Kedrion S.P.A. Recombinant Coagulation Factors Product
    Table 58. Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 59. Kedrion S.P.A. Recent Development
    Table 60. Novo Nordisk A/S Company Details
    Table 61. Novo Nordisk A/S Business Overview
    Table 62. Novo Nordisk A/S Recombinant Coagulation Factors Product
    Table 63. Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 64. Novo Nordisk A/S Recent Development
    Table 65. Octapharma AG Company Details
    Table 66. Octapharma AG Business Overview
    Table 67. Octapharma AG Recombinant Coagulation Factors Product
    Table 68. Octapharma AG Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 69. Octapharma AG Recent Development
    Table 70. Pfizer Inc. Company Details
    Table 71. Pfizer Inc. Business Overview
    Table 72. Pfizer Inc. Recombinant Coagulation Factors Product
    Table 73. Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2017-2022) & (US$ Million)
    Table 74. Pfizer Inc. Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Coagulation Factors Product Picture
    Figure 2. Global Recombinant Coagulation Factors Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Recombinant Coagulation Factors Market Size 2017-2028 (US$ Million)
    Figure 4. United States Recombinant Coagulation Factors Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Recombinant Coagulation Factors Market Size 2017-2028 (US$ Million)
    Figure 6. United States Recombinant Coagulation Factors Market Share in Global 2017-2028
    Figure 7. Recombinant Coagulation Factors Report Years Considered
    Figure 8. Product Picture of Recombinant Factor VIII
    Figure 9. Product Picture of Recombinant Factor IX
    Figure 10. Product Picture of Von Willebrand Factor
    Figure 11. Global Recombinant Coagulation Factors Market Share by Type in 2022 & 2028
    Figure 12. Global Recombinant Coagulation Factors Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Recombinant Coagulation Factors Market Share by Type (2017-2028)
    Figure 14. United States Recombinant Coagulation Factors Market Share by Type in 2022 & 2028
    Figure 15. United States Recombinant Coagulation Factors Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Recombinant Coagulation Factors Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Research Organizations
    Figure 20. Global Recombinant Coagulation Factors Market Share by Application in 2022 & 2028
    Figure 21. Global Recombinant Coagulation Factors Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Recombinant Coagulation Factors Market Share by Application (2017-2028)
    Figure 23. United States Recombinant Coagulation Factors Market Share by Application in 2022 & 2028
    Figure 24. United States Recombinant Coagulation Factors Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Recombinant Coagulation Factors Market Share by Application (2017-2028)
    Figure 26. North America Recombinant Coagulation Factors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Recombinant Coagulation Factors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Recombinant Coagulation Factors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Recombinant Coagulation Factors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Recombinant Coagulation Factors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Recombinant Coagulation Factors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Baxter International Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 55. Bayer AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 56. Biogen Idec Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 57. CSL Ltd. Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 58. Grifols International SA Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 59. Kedrion S.P.A. Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 60. Novo Nordisk A/S Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 61. Octapharma AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 62. Pfizer Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
Frequently Asked Questions
Recombinant Coagulation Factors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Coagulation Factors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Coagulation Factors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Remittance

Remittance market is segmented by region (country), players, by Type and by Application. Players, ... Read More